Bone Biologics Corp (BBLG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Operating Expenses | 3,040 | 3,148 | 1,287 | 1,219 | 469 |
| Operating Income | -3,040 | -3,148 | -1,287 | -1,219 | -469 |
| Other Income | 1,271 | -562 | 2,181 | 0 | 0 |
| Pre-tax Income | -1,769 | -3,710 | 894 | -1,219 | -469 |
| Net Income Continuous | -1,769 | -3,710 | 894 | -1,219 | -469 |
| Net Income | $-1,769 | $-3,710 | $894 | $-1,219 | $-469 |
| EPS Basic Total Ops | -31.25 | -331.13 | 148.69 | -169.41 | -65.27 |
| EPS Basic Continuous Ops | -31.31 | -331.12 | 144.01 | -169.60 | -65.28 |
| EPS Diluted Total Ops | -31.25 | -331.13 | 148.69 | -169.41 | -65.27 |
| EPS Diluted Continuous Ops | -31.31 | -331.12 | 144.01 | -169.60 | -65.28 |
| EBITDA(a) | $-3,040 | $-3,148 | $-1,287 | $-1,219 | $-469 |